Abstract:Background Demonstrated the great potential of facilitating bone regeneration, bone morphogenetic protein-2 (BMP-2) derived synthetic oligopeptide (S[PO4] KIPKASSVPTELSAISTLYLDDD, P24) has exhibited good osteoinductive and ectopic bone formation features. However, the defect of alveolar is always with irregular shapes and the bone formation is a long process, hence the application of P24 requires sustained release at certain concentration in irregular defects throughout the process of bone regeneration. Aim/Hypothesis We hypothesized that this P24-loaded hydrogel system could modulate osteogenic differentiation and hydrogel mineralization in vitro. After implanted in a rat critical size cranial defect, the composite hydrogels would be hypothesized to enhance bone regeneration. Materials and Methods PLGA-P24 microspheres were prepared with water-in-oil-in-water double emulsion. 10% nano hydroxyapatite (n-HA) and 5% PLGA-P24 microspheres were dispersed in 4% aldehyde dextran solution. Then composite hydrogel (CD n-HA PLGA-P24) was prepared via adding 0.5 ml mixture solution into 0.5 ml 4% hydroxypropyl chitosan solution. Consequently, we created a novel P24 sustained delivery system incorporated the Poly (lactic-co-glycolic acid) (PLGA) microspheres loaded P24 and n-HA microparticles into composite hydrogels. Then composite hydrogels were constructed, characterized, and tested for preosteoblastic (MC3T3-E1) in vitro. The osteoinductivity ability of composite hydrogel was tested by establishing an ectopic osteogenic model of the rat dorsal muscle pocket. After establishing the rat calvarial defect model, the bone defect was implanted the composite hydrogel with P24 microspheres to observe the ability of this composite system to repair the bone defect in vivo. Results The P24 peptides showed a sustained drug release profile over 60 days and markedly enhanced the efficiency in promoting the proliferation of cells and their expression of alkaline phosphatase (ALP). Additionally, the results of osteogenic gene expression and mineralization jointly confirmed that composite hydrogels could evoke a better cell osteodifferentiation viability in vitro. Through HE staining, Masson's trichrome staining and immunohistochemical staining, the results all above showed that the P24 microspheres composite hydrogel had a good osteoinductivity effect of ectopic osteogenic model in vivo. From the results of Micro CT, HE staining, Masson's trichrome staining and immunohistochemical staining in rat calvarial defect model, we knew that the composite hydrogel with P24-loaded microspheres composite hydrogel has a good ability to promote bone regeneration and is a potential bone tissue engineering material. Conclusion and Clinical Implications In this study, the osteogenic capability in vitro and regeneration capacity in vivo of a novel P24 sustained delivery system were investigated. The composite hydrogels enhanced the viability and osteogenic differentiation in vitro. In addition, the hydrogels had osteoinduction potential and promoted bone regeneration in vivo of rat ectopic bone formation and critical-sized calvarial defect model. In summary, the P24-hydrogel system construct could be a promising approach for bone regeneration.

Bone Induction Through Controlled Release of Novel Bmp-2-Related Peptide from Ptmc11-F127-Ptmc11 Hydrogels

Bone induction by biomimetic PLGA-(PEG-ASP)n copolymer loaded with a novel synthetic BMP-2-related peptide in vitro and in vivo

A Polysaccharide-based Hydrogel and PLGA Microspheres for Sustained P24 Peptide Delivery: an in Vitro and in Vivo Study Based on Osteogenic Capability

Sustained Delivery of BMP-2-Related Peptide from the True Bone Ceramics/Hollow Mesoporous Silica Nanoparticles Scaffold for Bone Tissue Regeneration

Click-based injectable bioactive PEG-hydrogels guide rapid craniomaxillofacial bone regeneration by the spatiotemporal delivery of rhBMP-2

A Polysaccharide‐based Composite Hydrogel Sustained Delivery P24 Peptide in PLGA Microsphere for Osteogenesis Potential in Vitro and in Vivo

Ectopic bone formation in vivo induced by a novel synthetic peptide derived from BMP-2 using porous collagen scaffolds

Bone Morphogenetic Protein-2 Derived Peptide Loaded Calcium Sulfate Hemihydrate Scaffold for Enhanced Bone Tissue Regeneration

Zero-order controlled release of BMP2-derived peptide P24 from the chitosan scaffold by chemical grafting modification technique for promotion of osteogenesis in vitro and enhancement of bone repair in vivo

Biomimetic ECM coatings for controlled release of rhBMP-2: construction and biological evaluation

Sustained Delivery of PlGF-2123-144*-fused BMP2-related Peptide P28 from Small Intestinal Submucosa/polylactic Acid Scaffold Material for Bone Tissue Regeneration

Bone induction by biomimetic PLGA copolymer loaded with a novel synthetic RADA16-P24 peptide in vivo.

Bone Induction by Surface-Double-modified True Bone Ceramicsin Vitroandin Vivo

An injectable carboxymethyl chitosan-based hydrogel with controlled release of BMP-2 for efficient treatment of bone defects

Programmed Sustained Release of Recombinant Human Bone Morphogenetic Protein-2 and Inorganic Ion Composite Hydrogel As Artificial Periosteum

Bioactive Polyetheretherketone with Gelatin Hydrogel Leads to Sustained Release of Bone Morphogenetic Protein-2 and Promotes Osteogenic Differentiation

Bone Formation in Ectopic and Osteogenic Tissue Induced by a Novel BMP-2-related Peptide Combined with Rat Tail Collagen

[Experimental study on ectopic osteogenesis induced by bone morphogenetic protein 2-derived peptide P24 loaded chitosan-4-thio-butylamidine hydrogel]

A new bone-inducing biodegradable porous beta-tricalcium phosphate

Calcium sulfate hemihydrate/mineralized collagen for bone tissue engineering: In vitro release and in vivo bone regeneration studies

Using poly(lactic-co-glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo.